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Abstract
Background: Several kinds of anti-oxidants have drawn a lot of intension for their benefits on
vascular protection. In addition, it has been demonstrated that exercise training could improve
endothelial function by up-regulating endothelial nitric oxide synthase (eNOS) protein. Therefore,
the present study aims to investigate the effects of genistein, a potent phyto-antioxidant, and
exercise training on age-induced endothelial dysfunction in relation to NO bioavailability using in
situ NO-sensitive fluorescent dye detection.
Methods: Male Wistar rats (20-22-month old) were divided into four groups: aged rats treated
with corn oil, (Aged+Veh, n = 5), aged rats treated with genistein (Aged+Gen, n = 5, (0.25 mg/kg
BW/day, s.c.)), aged rats with and without exercise training (Aged+Ex, n = 5, swimming 40 min/day,
5 days/week for 8 weeks) (Aged+Without-Ex, n = 5). Cremaster arterioles (15-35 micrometer)
were visualized by fluorescein isothiocyanate labeled dextran (5 microgram/ml). The vascular
response to acetylcholine (Ach; 10-5M, 5 ml/5 min) was accessed after 1-min norepinephrine
preconstriction (10 micro molar). To determine NO bioavailability, the Krebs-Ringer buffer with
4, 5-diaminofluorescein-diacetate (3 micro molar DAF-2DA), and 10 micro- molar Ach saturated
with 95%N2 and 5%CO2 were used. Changes of DAF-2T-intensities along the cremaster arterioles
were analyzed by the Image Pro-Plus Software (Media Cybernatics, Inc, USA). Liver
malondialdehyde (MDA) level was measured by thiobarbituric acid reaction and used as an
indicator for oxidative stress.
Results: The results showed that means arterial blood pressure for both Aged+Gen and Aged+Ex
groups were significantly reduced when compared to the Aged groups, Aged+Veh and
Aged+Without-Ex (P < 0.05). Among the treated groups, Ach-induced vasodilatation were
significantly increased (P < 0.05) and was associated with increased NO-associated fluorescent
intensities (P < 0.05). On the other hand, MDA levels were significantly reduced (P < 0.05) when
Aged+Veh was compared to Aged+Without-Ex.
Conclusion:  These findings showed that genistein and exercise training could improve age-
induced endothelial dysfunction and is related to the increased NO bioavailability.
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Background
Aging is a dependent risk factor for the development of
vascular diseases in association with a progressive
endothelial dysfunction [1,1]. It is believed that reduced
basal endothelium-derived vasodilators, such as nitric
oxide (NO), contribute to the age-related increase in
peripheral vascular resistance and systemic hypertension
[3,3]. From epidemiological and experimental studies,
they have shown that an increased superoxide (O2
-) pro-
duction with advancing age causes oxidative stress and
leads to the development of endothelial dysfunction [5-
10]. Superoxide (O2
-) is a free radical that can rapidly
scavenge NO directly, and this age-induced oxidative
stress may contribute to the reduction of NO bioavailabil-
ity [11]. Therefore, several studies have investigated the
roles of phyto-substances with anti-oxidative properties
and their benefits as vasculoprotective agents. As of note,
especially in East Asian population, high plasma concen-
tration of genistein, a soy product, contributes to a strik-
ingly low incidence of atherosclerosis and coronary heart
disease [12-14]. It has been reported that genistein, a phy-
toestrogen acting as estrogenic cardioprotector [13], could
enhance coronary vasoreactivity and inhibit the oxidative
stress [15-17]. Genistein, an anti-oxidant, could produce
acute NO-dependent vasodilatation in the forearm vascu-
lature of men and women with potency similar to that of
17β-estradiol [18-22]. Moreover, aerobic exercise training
appears to reverse old age-associated reductions in
endothelium-dependent vasodilatation in humans
[2,23,24]. Therefore, we evaluate the effects of genistein
and exercise training on protecting endothelial cells
against age-induced oxidative stress by using a fluorescent
indicator-diaminofluorescein (DAFs). This technique
allowed us to examine the in situ release of NO from cre-
masteric endothelial cells after acetylcholine activation.
Methods
Animal preparation
The present study was conducted in accordance with the
guidelines for animal experimentation of the National
Research Council of Thailand and approved by Ethical
Committee, Faculty of Medicine, Chulalongkorn Univer-
sity.
Male Wistar rats aged 20-22 months (n = 20) were used in
this study. The animals were obtained from National Lab-
oratory Animal Center, Salaya Campus, Nakhonprathom,
Thailand, and housed in the animal laboratory center at
the Faculty of Medicine, Chulalongkorn University until
they were used. The rats were fed with the standard chow
and drank tap water ad libitum. The room was temperature
controlled at 25°C, and has a 12:12-light-dark cycle. The
old rats were randomly divided into four groups: aged rats
treated with corn oil (Aged+Veh (n = 5); Sigma-Aldrich
Co., USA), aged rats treated with genistein (Aged+Gen, (n
= 5); Sigma-Aldrich Co., USA, 0.25 mg/kg BW/day, s.c.)
[19], and aged rats with exercise training (Aged+Ex (n =
5)). Aged+Gen rats received genistein injection every day
for 8 weeks. For the Aged+Ex group, swimming exercise
training protocol was conducted in 2 phases, adaptation
and training. The adaptation phase consisted of the first 5
days of training. On the first day, the animals exercised in
a round plastic tank (diameter = 38.5 cm, depth= 35 cm,
water temperature about 34-36°C) for 10 minutes. The
exercise period was extended by 10 minutes every day
until the rats could swim for 40 minutes. The training
phase consisted of swimming 40 min/day, 5 days/week
for a total of 8 weeks [25]. Swimming exercise was selected
because it did not cause foot injuries, and is physically less
traumatic for the animal. In the Aged+Without-Ex group
(n = 5), the rats were immersed in water as to make them
wet for 30 min/day, 5 day/week for a total of 8 weeks [25].
As of note, in this study, male Wistar rats aged 4-6 months
(n = 5) were used as controls.
On week 8, all rats were anesthetized intraperitoneally
with pentobarbital sodium (50 mg/kg BW). After trache-
otomy, a polyethylene tube was inserted into the carotid
artery to measure the arterial blood pressure. The jugular
vein was cannulated for fluorescence tracer. In vivo micro-
circulatory observations were performed in the cremaster
muscle according to the methods described by Gavins et
al. (2004) [26]. The cremaster muscle was carefully spread
over a chamber that was continuously perfused with 37°C
Krebs-Ringer buffer (composition in mmol/L: 135.7
NaCl, 4.7 KCl, 2.52 CaCl2, 1.18 KH2PO4, 1.64
MgSO4.7H2O, and 7.14 NaHCO3) at pH 7.4 and equili-
brated with 5%CO2-95%N2. The rate of perfusion was
kept constant at 2 ml/min [26].
Arteriolar response to acetylcholine and sodium 
nitroprusside
The second or third-order cremasteric arterioles (15 to 35
μm in diameter) were labeled with 5% fluorescein isothi-
ocyanate-labeled dextran (FITC-dextran 250, 5 μg/ml;
Sigma-Aldrich Co., USA) which was injected into the jug-
ular vein. After the arterioles were pre-constricted with
norepinephrine (10-5M NE; 0.1 ml/min), it was later
dilated by applying acetylcholine (10-5M Ach; 5 ml/5
min) topically. The changes of vascular diameters were
recorded real time throughout the experiment with a
black and white video monitor (Sony, GM-1411 QM) and
an epi-illumination fluorescence videomicroscopy system
(Optiphot 2, Nikon, Japan) equipped with a 100 W mer-
cury lamp, real time CCD camera (Hamamatsu C2400,
Japan), a video recorder (VC-S5, Sharp, Japan) with a
video timer (VTG-33, For-A, Japan) and a 20 × objective
lens (CF Plan Fluor, Nikon, Japan). Cremasteric arteriolar
diameter was measured by using the software (Image-Pro
Plus; Media Cybernatics, Inc, USA). The arteriolar diame-Reproductive Biology and Endocrinology 2009, 7:93 http://www.rbej.com/content/7/1/93
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ter was calculated by averaging three measurements
obtained from three different video frames using the same
reference point as a marker for measuring each vessel in
each frame. Arteriolar diameters were measured five min-
utes after Ach administration. Vasodilatation responses
were expressed as the percentage of maximal relaxation
after norepinephrine (NE; 10-5M) preconstriction.
Under the same protocol, after the arteriole was selected,
it was washed by Krebs-Ringer solution (pH 7.4) until its
diameter was returned to normal. The SNP (10-5M; 5 ml/
5 min), an endothelium-independent vasodilator, was
applied topically on the arterioles after it was pre-con-
stricted with NE. Vasodilatation responses were expressed
as the percentage of maximal relaxation after norepine-
phrine (NE; 10-5M) preconstriction.
Direct detection of NO production
On the experiment day, the cremaster microcirculation
was observed under intravital fluorescent video micro-
scope with a 20 × objective lens and a 10 × eyepieces. To
visualize microvascular distribution of NO, diaminofluo-
rescein-2 (DAF-2DA, Cayman Chemical Company, Mich-
igan, USA), a NO-sensitive fluoroprobe, was used. After
the cremaster was superfused with Krebs- Ringer buffered
solution containing 3 μM DAF-2DA and 10-5M Ach, NO
levels from Ach-activated endothelial cells were analyzed
at two different time points, 0 min (I0 min) and 20 mins
(I20 min) [27,27].
DAF-2DA can readily enter the cells and hydrolyzed by
cytosolic esterase to DAF-2, which is trapped inside the
cells. In the presence of NO, the relatively non-fluorescent
DAF-2 is converted into a highly green fluorescent triazole
form, DAF-2T (shown in diagram below). Thus the
increases in DAF-2T fluorescent intensity represent of the
cremasteric microcirculation would indicate an elevation
of nitric oxide having by an excitation and emission wave-
lengths of 488 and 538 nm, respectively [27,27,29].
The cremasteric microcirculation was epi-illuminated
having an excitation wavelength of 488 nm and emission
wavelength of 538 nm. The microscopic field containing
arterioles (15 to 35 μm in diameter) sharing the same
focusing plane were selected and recorded for further
analysis using Image Pro-Plus V. 5 software. (Media
Cybernatics, Inc, USA). From fourteen small working win-
dow frames (7 × 3 μm2 each window), the fluorescent
intensity of each arteriolar vascular wall was averaged
(Figure 1). Assuming that DAF-2T intensity is linearly
related to the intracellular NO content, the difference in
fluorescent intensity between I0 min and I20 min was calcu-
lated according to the following equation and represented
as the percent increase in NO released during the first 20
minutes:
Measurement of metabolic parameters
At the end of each experiment, the blood sample of each
rat was collected to determine the androgen level. Imme-
diately after that, the liver was perfused with ice-cold
phosphate buffer saline (PBS) at pH 7.4 and excised. All
fat and fibrous tissues on the liver were removed before it
was weighed. The liver was kept at -80°C until malondial-
dehyde (MDA) analyses were done. MDA was performed
by using the thiobarbituric acid reaction as described by
Ohkawa et al., 1979 [31].
Statistical analyses
Data are expressed as means ± SD. For comparison among
groups of animals, one-way analysis of variance (one-way
ANOVA) and a two-sided alpha level of 0.05 adjusted by
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This figure showed a videoimage of NO-associated fluores- cent intensity taken from cremasteric arteriole of a young rat  by using 20 ×-objective lenses Figure 1
This figure showed a videoimage of NO-associated 
fluorescent intensity taken from cremasteric arteri-
ole of a young rat by using 20 ×-objective lenses. From 
14 frames of working windows, the Histogram Menu in 
Image Program Software was used to define the mean value 
of fluorescent intensity of each window, and then the aver-
aged intensity was calculated for all 14 small working window 
frames (7 × 3 μm2 each window). The intensity difference 
(Idiff) between the averaged intensities obtained at 20 min (I20 
min) and at baseline (I0 min) were calculated and represented 
by the percentage change in intensity from its baseline value, 
using the following equation: %Change of NO-associated flu-
orescent intensity = (I20 min- I0 min/I0 min)×100
Figure 1Reproductive Biology and Endocrinology 2009, 7:93 http://www.rbej.com/content/7/1/93
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Tukey's procedure for multiple comparisons were used. P
< 0.05 was considered statistically significant.
Results
Physiological characteristics
In Table 1, the results showed that means arterial pressure
(MAP) for age-groups (Aged+Veh; 144.68 ± 5.93 mmHg,
and Aged+Without-Ex; 144.20 ± 18.62) were significantly
higher than the young group (4-6-mo-old; 121.55 ± 3.43
mmHg) (P < 0.01). However, MAP from both Aged+Gen
(124.58 ± 2.41 mmHg) and Aged+Ex rats (124.20 ± 5.31
mmHg) reduced significantly when it was compared to
their age- matched control groups (P < 0.05). Testosterone
levels and the ratios of seminal vesicle/body weights were
significantly decreased in Aged+Veh (0.71 ± 0.74 ng/mL
and 0.0023 ± 0.0005) and Aged+Without-Ex groups (0.67
± 0.77 ng/mL and 0.0023 ± 0.0018) when compared to
the young group (2.01 ± 1.31 ng/mL and 0.0044 ±
0.0008) (P < 0.05). Genistein supplementation showed
no effects on both testosterone level and the ratio of sem-
inal vesicle/body weight. However, in Aged+Ex group, the
ratio of seminal vesicle/body weight was significantly
higher than the Aged+Without-Ex group (Aged+Ex =
0.0042 ± 0.0006, Aged+Without-Ex = 0.0023+0.0018) (P
< 0.05). This may be due to the effect of exercise training
on the fat composition, because there were no significant
differences between seminal vesicle weight of the Aged+Ex
and Aged+Without-Ex groups.
Levels of liver malondialdehyde
Indicators of oxidative stress, liver-malondialdehyde
(MDA), of Aged+Veh (4.81 ± 1.17 μmol/g liver wet
weight) and Aged+Without-Ex (4.33 ± 2.00 μmol/g liver
wet weight) were significantly higher when compared to
the young group (2.42 ± 0.48 μmol/g liver wet weight) (P
< 0.05). But the MDA levels of two treated groups,
Aged+Gen (2.53 ± 0.59 μmol/g liver wet weight) and
Aged+Ex (2.51 ± 0.49 μmol/g liver wet weight), were sig-
nificantly lower when compare to their age-matched con-
trols (P < 0.05) (Table 1).
Acetylcholine-induced arteriolar response
As shown in Figure 2, arteriolar dilatation to Ach was sig-
nificantly impaired in Aged+Veh (11.07 ± 2.83%) when it
was compared to the young group (26.51 ± 5.60%) (P <
0.05). Interestingly, the dilatory responses of the arterioles
to Ach significantly increased in both Aged+Gen (27.41 ±
8.75%) and Aged+Ex (31.15 ± 4.58%) groups when com-
pared to their age-matched controls (P < 0.05 and P <
0.001, respectively).
Sodium nitroprusside-induced arteriolar response
To ensure that impairment of arteriolar dilatation to Ach
did not interfere with the function of the smooth muscle
cells, the vasodilatory response to endothelium-inde-
pendent vasodilatation was examined by using SNP (10-
5M). The results showed that there was no significant dif-
ference among the young (25.88 ± 3.70%), Aged groups
(Aged+Veh, (29.79 ± 11.71%), and Aged+Without-Ex
groups (32.15 ± 16.56%)) (Figure 3).
Direct detection of NO production
In Figure 4, the NO production was significantly lower in
the aged groups (Aged+Veh (35.01 ± 9.71%) and
Aged+Without-Ex (38.47 ± 7.84%) when compared to the
young group (85.74 ± 17.99%) (P < 0.001). Interestingly,
both Aged+Gen (76.64 ± 18.52%) and Aged+Ex (80.86 ±
15.62%) groups had a significant enhancement of the NO
level when compared to their age-matched controls
(Aged+Veh and Aged+Without-Ex) (P < 0.05). It is noted
that genistein and exercise training could enhance NO
bioavailability in aging rats.
In Figure 5, linear regression was performed to establish
the relationship between the Ach-induced increase in arte-
riolar diameters and the percent increased in NO-associ-
ated fluorescent intensity for the young, Aged+Veh,
Aged+Gen, Aged+Without-Ex and Aged+Ex groups. The
linear equation obtained was: y = 0.3567x - 0.7287, R2 =
0.87, (P < 0.01), where x is the mean of NO-associated flu-
orescent intensity and y is the mean percentage of diame-
ter change.
Table 1: Means ± SD of physiological and biochemical characteristics of young, aged rats with vehicle (Aged+Veh), genistein 
(Aged+Gen), without exercise training (Aged+Without-Ex), and exercise training (Aged+Ex).






MDA level of liver 
(μmol/g wet wt.)
Young (n = 5) 121.55 ± 3.43 2.01 ± 1.31 2.09 ± 0.38 0.0044 ± 0.0008 2.42 ± 0.48
Aged+Veh (n = 5) 144.68 ± 5.93** 0.71 ± 0.74* 1.74 ± 0.33 0.0023 ± 0.0005* 4.81 ± 1.17*
Aged+Gen (n = 5) 124.58 ± 2.41# 1.13 ± 0.73 2.49 ± 0.67 0.0036 ± 0.0008 2.53 ± 0.59#
Aged+Without-Ex 
(n = 5)
144.20 ± 18.62** 0.67 ± 0.77* 1.54 ± 1.31 0.0023 ± 0.0018* 4.33 ± 2.00*
Aged+Ex (n = 5) 124.20 ± 5.31† 0.34 ± 0.09 2.87 ± 0.29 0.0042 ± 0.0006† 2.51 ± 0.49†
*P < 0.05 compared with young group, **P < 0.01 compared with young group, #P < 0.05 compared with Aged+Veh group, †P < 0.05 compared with 
Aged+Without-Ex group.Reproductive Biology and Endocrinology 2009, 7:93 http://www.rbej.com/content/7/1/93
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Discussion
In the present study, we have shown that soy phytoestro-
gen, genistein, and 8-week exercise training could reduce
the age-induced cardiovascular abnormalities, such as
hypertension and age-induced endothelial dysfunction.
These treatments can increase NO bioavailability to have
a linear correlation with endothelial-dependent vasodila-
tation improvement.
Since it is well known that age-induced oxidative stress
can cause abnormal vascular functions by enhancing
resistance to blood flow, hence, in this study, we meas-
ured the MDA levels in liver of the rats from the age-
groups. The condition of the age-induced oxidative stress
was indicated by an elevated MDA level which can con-
tribute to the sequential process, age-induced endothelial
dysfunction [8,8]. In the report of Taddei et al. [9], it has
been confirmed that the response to acetylcholine
declined with age. Moreover, it has been suggested that
the phenomenon of age-induced endothelial dysfunction
is widespread and applies to the whole circulation [32].
For that reason, it is possible to increase the total periph-
eral vascular resistance and MAP in the aged group.
The percentage of increase in arteriolar diameters induced  by Ach for young, aged rats with vehicle (Aged+Veh), genis- tein (Aged+Gen), without exercise training (Aged+Without- Ex), and exercise training (Aged+Ex) Figure 2
The percentage of increase in arteriolar diameters 
induced by Ach for young, aged rats with vehicle 
(Aged+Veh), genistein (Aged+Gen), without exercise 
training (Aged+Without-Ex), and exercise training 
(Aged+Ex). *P < 0.05 compared with young group, #P < 
0.05 compared with Aged+Veh group, ††P < 0.01 compared 
with Aged+Without-Ex group.
Figure 2
The percentage change of arteriolar diameters induced by  SNP for young, aged rats with vehicle (Aged+Veh), genistein  (Aged+Gen), without exercise (Aged+Without-Ex) and  exercise (Aged+Ex) Figure 3
The percentage change of arteriolar diameters 
induced by SNP for young, aged rats with vehicle 
(Aged+Veh), genistein (Aged+Gen), without exercise 
(Aged+Without-Ex) and exercise (Aged+Ex). No sig-
nificantly difference as compared to young group. No signifi-
cantly difference as compared to Aged groups.
Figure 3
The percentage change of NO-associated fluorescent inten- sity for young, aged rats with vehicle (Aged+Veh), genistein  (Aged+Gen), without exercise (Aged+Without-Ex) and  exercise (Aged+Ex) Figure 4
The percentage change of NO-associated fluorescent 
intensity for young, aged rats with vehicle 
(Aged+Veh), genistein (Aged+Gen), without exercise 
(Aged+Without-Ex) and exercise (Aged+Ex). *P < 
0.05 compared with young group, #P < 0.05 compared with 
Aged+Veh group, †P < 0.05 compared with Aged+Without-
Ex group.
Figure 4
The correlations between percent changes of NO-associated  fluorescent intensity and the percent arteriolar diameter  changes were examined by using Pearson's Correlation and  the best-fitting linear regression Figure 5
The correlations between percent changes of NO-
associated fluorescent intensity and the percent arte-
riolar diameter changes were examined by using 
Pearson's Correlation and the best-fitting linear 
regression. All data were taken from values of each groups: 
young, aged+vehicle (Aged+Veh), aged+genistein 
(Aged+Gen), aged+without exercise (Aged+Without-Ex) 
and aged+exercise (Aged+Ex). (Pearson's correlation = 0.87, 
P < 0.01).
Figure 5Reproductive Biology and Endocrinology 2009, 7:93 http://www.rbej.com/content/7/1/93
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The results from the MDA levels showed that long-term
treatment of genistein can scavenge the age-induced
excess free radicals, especially superoxide anions which
can directly damage molecules of protein, lipid, and DNA
as which leads to cell dysfunction. Our observation of
increased Ach-induced vasodilatation in Aged+Gen group
confirms that anti-oxidant agent can prevent age-induced
endothelial dysfunction. This ability may enhance
endothelial-dependent vasodilatation by protecting NO
from direct interaction with the superoxide radical. Since
NO bioavailability is associated with endothelium-
dependent vasodilatation, the greater NO bioavailability
level, therefore, a more pronounced endothelium-
dependent vasodilatation effect will be observed.
Furthermore, many investigators are interested in genis-
tein's mechanism and how it is able to increase NO bioa-
vailability [21,21]. For example, Walker et al. showed that
genistein, 17β-estradiol, can produce acute NO-depend-
ent vasodilatation which may affect endothelial nitric
oxide synthase (eNOS) activity [22]. On the other hand, it
has been shown that genistein has a similar affinity as
estrogen because of the novel ER-β present in the vascula-
ture [21]. The ER-β in endothelial cell has been shown to
stimulate NO-production also known as the non-genomic
effect of estrogen [33]. Interestingly, it has been shown
that acute topical application of genistein mediated
vasodilatation via prostacyclin (PGI2) and NO produc-
tions [34].
Yet, other investigations indicated that an acute action of
genistein-induced endothelial NO production was medi-
ated by another pathway of protein kinase A (PKA) which
is unrelated to the estrogenic effect [35]. They also sug-
gested that this pathway may be crucial in protecting the
cardiovascular effects seen in soy phytoestrogens. For
example, Liu et al. (2004) [35] demonstrated that 1-μM
genistein could directly activate eNOS in intact bovine
aortic endothelial cells and endothelial cells from human
umbilical vein over an incubation period of 10 minutes.
They also proposed that these effects were mediated by
PKA and were unrelated to the estrogenic effect. In
another report, Si et al. (2008) showed that genistein had
a direct genomic effect on the vascular wall causing an
increased eNOS expression and NO synthesis in sponta-
neously hypertensive rat model [36].
Our result (Table 1) confirmed that both testosterone lev-
els and ratios of seminal weights were significantly
decreased by aging. Genistein supplementation and exer-
cise training did not affect those parameters. Other studies
have reported similar findings that low doses of phytoes-
trogens do not have any effects on reproductive functions
of either males or females [37,37]. However, the increased
seminal vesicle/body weight ratio in Aged+Ex group may
have been from the metabolic effect of exercise training on
fat composition leading to weight loss in this group.
Aside from that, our findings indicated that genistein and
exercise training could protect endothelial functions from
age-induced dysfunction. A significant reduction in MDA
levels in Aged+Ex group was observed when compared to
the Aged+Without-Ex group (Table 1). These results con-
firmed the effectiveness of our training protocol, 40 min/
day, 5 day/week for a total of 8 weeks, in reducing periph-
eral vascular resistance in aged male rat. The following
might help explain the benefits of long-term exercise
training: 1) reduction of age-induced oxidative stress by
increasing the enzymatic anti-oxidants expression, and 2)
an increase in shear-stress mediated eNOS activity [39].
Also Ahmadiasl and colleagues (2007) showed that long-
term endurance training could increase superoxide dis-
mutase (SOD) activities in rat myocardium [40]. There are
several approaches that may explain how exercise training
can enhance endothelial function, yet the effects of endur-
ance exercise training on the oxidative status and antioxi-
dant defense system remain unclear. Discrepancies are
due to different training protocols used and, therefore,
caution is warranted in interpreting these results.
Nevertheless, in our study, a moderate exercise training
program consisting of 8 weeks is sufficient enough to
reduce age-induced endothelium dysfunction. It appears
to us that exercise training has the same effects as seen in
genistein because of its ability to protect NO bioavailabil-
ity in the Aged group and enhance endothelium-depend-
ent vasodilatation. The reason for this may be that exercise
training improves endothelial function and provides car-
dioprotective benefits.
Additional analysis using an in vitro study, Kashiwagi et al.
(2002) showed a linear relationship between the gray lev-
els of fluorescence intensities and DAF-2T concentrations
(between 10 nmol/L and 1 μmol/L) [27]. For this reason,
we chose to further investigate whether there are any cor-
relation between NO-associated fluorescent intensity and
the Ach-evoked vasodilatation in all five groups. Our cor-
relation results between the means percent changes of
NO-associated fluorescent intensity and the mean percent
of arteriolar diameter changes from all 5 groups were sig-
nificantly correlated and are shown in Figure 5 (Pearson's
correlation = 0.87, P < 0.01). These findings suggested that
Ach-induced arteriolar dilatation could be restored by
using genistein and exercise training to increase intra-
endothelial NO bioavailability.
The results obtained showed an increase of NO bioavaila-
bility after utilizing two interventions. Both of these inter-
ventions have multiple functions effecting eNOSReproductive Biology and Endocrinology 2009, 7:93 http://www.rbej.com/content/7/1/93
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expression, eNOS activity, and eNOS cofactor; tetrahydro-
biopterin (BH4).
Both interventions can increase eNOS expression through
both direct and indirect pathways [35,36,41,42]. Simi-
larly, Tanabe and his colleagues (2003) reported that the
8-week exercise swimming could up-regulate eNOS
expression in the aorta in aged rats [41]. Along the same
lines, Sindler et al. (2009) suggested that exercise training
can restore the important eNOS cofactor, tetrahydrobi-
opterin (BH4), content and then leads to enhance flow-
stimulated NO availability in old rats [42].
Our findings parallel previous research showing NO bio-
availability enhances endothelium-dependent vasodilata-
tion. Our results may be the first in vivo evidence of
genistein and exercise training in protecting endothelial
cells against age-induced oxidative stress by using a fluo-
rescent indicator-diaminofluorescein (DAFs). The in situ
release of NO from cremasteric endothelial cells after ace-
tylcholine activation was examined in both genistein and
exercise training groups. The effect of genistein and exer-
cise training on increased NO bioavailability may be asso-
ciated with multiple direct and indirect pathways and
additional studies are needed to confirm these results.
Conclusion
The findings indicated that long-term genistein treatment
and exercise training could improve age-induced endothe-
lial dysfunction in cremasters and increase NO bioavaila-
bility in aging male rats.
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